These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26704983)

  • 1. Periodic-shRNA molecules are capable of gene silencing, cytotoxicity and innate immune activation in cancer cells.
    Shopsowitz KE; Wu C; Liu G; Dreaden EC; Hammond PT
    Nucleic Acids Res; 2016 Jan; 44(2):545-57. PubMed ID: 26704983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-delivered antisense RNA and shRNA exhibit different silencing efficiencies for the endogenous transforming growth factor-beta (TGF-beta) type II receptor.
    Ogorelkova M; Zwaagstra J; Elahi SM; Dias C; Guilbaut C; Lo R; Collins C; Jaramillo M; Mullick A; O'Connor-McCourt M; Massie B
    Oligonucleotides; 2006; 16(1):2-14. PubMed ID: 16584291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual effects of duplex RNA harboring 5'-terminal triphosphate on gene silencing and RIG-I mediated innate immune response.
    Baek SE; Kim H; Kim KB; Yoon S; Choe J; Suh W; Jeong YJ; Cho YH; Kim DE
    Biochem Biophys Res Commun; 2015 Jan; 456(2):591-7. PubMed ID: 25490387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branch-PCR Constructed Stable shRNA Transcription Nanoparticles Have Long-Lasting RNAi Effect.
    Liu J; Wang R; Ma D; Li Y; Wei C; Xi Z
    Chembiochem; 2016 Jun; 17(11):1038-42. PubMed ID: 26972444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of RNA interference in nasopharyngeal carcinoma cell lines using reporter genes].
    Yin ZH; Ren CP; Li F; Jiang WH; Yang XY; Feng XL; Yao KT
    Ai Zheng; 2005 Mar; 24(3):371-5. PubMed ID: 15757546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(beta-amino ester) as a carrier for si/shRNA delivery in lung cancer cells.
    Jere D; Xu CX; Arote R; Yun CH; Cho MH; Cho CS
    Biomaterials; 2008 Jun; 29(16):2535-47. PubMed ID: 18316120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering Periodic shRNA for Enhanced Silencing Efficacy.
    Wu C; Shopsowitz KE; Hammond PT
    Mol Ther; 2016 Jun; 24(6):1070-1077. PubMed ID: 27053374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nuclear factor-κB activity by small interfering RNA in esophageal squamous cell carcinoma cell lines.
    Hatata T; Higaki K; Nanba E; Tatebe S; Ikeguchi M
    Oncol Rep; 2011 Sep; 26(3):659-64. PubMed ID: 21617867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.
    Fish RJ; Kruithof EK
    BMC Mol Biol; 2004 Aug; 5():9. PubMed ID: 15291968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer.
    Chowdhury N; Vhora I; Patel K; Doddapaneni R; Mondal A; Singh M
    Pharm Res; 2017 Nov; 34(11):2371-2384. PubMed ID: 28875330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of FoxO4 Activity and Cell Survival by TRIM22 Directs TLR3-Stimulated Cells Toward IFN Type I Gene Induction or Apoptosis.
    Oteiza A; Mechti N
    J Interferon Cytokine Res; 2015 Nov; 35(11):859-74. PubMed ID: 26237181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-kappaB and/or IRF-3 in airway epithelial cells.
    Matsukura S; Kokubu F; Kurokawa M; Kawaguchi M; Ieki K; Kuga H; Odaka M; Suzuki S; Watanabe S; Takeuchi H; Kasama T; Adachi M
    Clin Exp Allergy; 2006 Aug; 36(8):1049-62. PubMed ID: 16911361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activation.
    Ittah M; Miceli-Richard C; Gottenberg JE; Sellam J; Lepajolec C; Mariette X
    Eur J Immunol; 2009 May; 39(5):1271-9. PubMed ID: 19337998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-responsive polymeric micelles formed by conjugating gambogic acid with bioreducible poly(amido amine)s for the co-delivery of docetaxel and MMP-9 shRNA.
    Kang Y; Lu L; Lan J; Ding Y; Yang J; Zhang Y; Zhao Y; Zhang T; Ho RJY
    Acta Biomater; 2018 Mar; 68():137-153. PubMed ID: 29288085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-step assembly of polymeric demethylcantharate prodrug/Akt1 shRNA complexes for enhanced cancer therapy.
    Zhang JL; Gong JH; Xing L; Cui PF; Qiao JB; He YJ; Zhang M; Lyu JY; Luo CQ; Che SA; Jin T; Jiang HL
    Int J Pharm; 2016 Nov; 513(1-2):612-627. PubMed ID: 27682215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.
    Liu R; Sun J; Zhang Z; Xu Y
    Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
    Xu P; Jiang YF; Wang JH
    Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of viral hemorrhagic septicemia virus replication using a short hairpin RNA targeting the G gene.
    Kim MS; Kim KH
    Arch Virol; 2011 Mar; 156(3):457-64. PubMed ID: 21184243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in RNA sensing by the immune system: separation of siRNA unwanted effects from RNA interference.
    Sioud M
    Methods Mol Biol; 2010; 629():33-52. PubMed ID: 20387141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
    He HN; Wang X; Zheng XL; Sun H; Shi XW; Zhong YJ; Huang B; Yang L; Li JK; Liao LC; Zhang L; Hu LN; Lin Y
    Cancer Lett; 2010 Sep; 295(1):38-43. PubMed ID: 20207071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.